Unlock Your Pharmaceutical Manufacturing Potential in Pakistan
Establishing and operating a pharmaceutical manufacturing facility in Pakistan demands rigorous adherence to national regulations. Navigating the complex landscape of drug manufacturing licenses, GMP certifications, and ongoing compliance can be challenging. Javid Law Associates offers comprehensive support to ensure your pharmaceutical venture meets all statutory requirements, from initial licensing applications to sustained operational compliance.
Our Pharmaceutical Licensing & Compliance Services Include:
We provide end-to-end solutions designed to facilitate your pharmaceutical manufacturing journey, ensuring every step is compliant and efficient. Our services cover the acquisition of all necessary permits and certifications, alongside robust strategies for ongoing regulatory adherence.
Key Regulatory Authorities & Frameworks
Our expertise spans critical regulatory bodies and frameworks vital for pharmaceutical manufacturing in Pakistan, including:
- Drug Regulatory Authority of Pakistan (DRAP): For drug manufacturing licenses, product registration, and import permits.
- Good Manufacturing Practices (GMP): Ensuring your facility meets international and national quality standards.
- Ministry of National Health Services, Regulations and Coordination (NHSR&C): Overseeing health-related policies and regulations.
- Federal Board of Revenue (FBR): For tax registration (NTN) and compliance relevant to manufacturing operations.
Why Choose Javid Law Associates for Your Pharma Compliance?
With over two decades of experience in Pakistani corporate and legal matters, Javid Law Associates is your trusted partner. We leverage our deep understanding of regulatory processes and our established relationships with authorities to expedite your licensing and ensure sustained compliance. Our commitment is to provide swift, hassle-free, and expert guidance.
Service Coverage & Benefits
Our comprehensive support covers all aspects of pharmaceutical manufacturing licensing, including initial application preparation, liaison with DRAP and other bodies, GMP certification guidance, and post-licensing compliance monitoring. This ensures operational continuity, avoids penalties, and builds credibility in the market.
Estimated Timeline & Investment
| Service Phase | Estimated Duration |
|---|---|
| License Application & Processing | 30-45 days |
| GMP Certification Support | 20-30 days (concurrently) |
| Overall Compliance Setup | 45-60 days |
The investment for this comprehensive service is 50,000 PKR. This includes all professional fees for initial consultation, application preparation, submission, and liaison. Government fees are separate and will be communicated upfront.
Ready to Start?
Contact us today for a personalized consultation and let us guide you through the pharmaceutical licensing and compliance process in Pakistan. We are committed to providing efficient and effective solutions for your business needs.
Service heading
Navigate Pakistan's pharmaceutical licensing and ensure seamless regulatory compliance for your manufacturing operations.
Estimated duration
45-60 days
Documentation & Requirements
Clear breakdown of client-provided records and deliverables prepared by our advocates
- Company registration documents (SECP)
- Details of manufacturing facility (location, capacity)
- Proposed product list and formulations
- Key personnel qualifications and CVs
- Proof of payment of relevant government fees
- Prepared directly by our legal advisory team.
Key features
- DRAP Drug Manufacturing License Application
- GMP Certification Guidance & Support
- Product Registration Assistance
- Ongoing Regulatory Compliance Advisory
- Liaison with Health Authorities
- FBR NTN Registration for Manufacturing
- Timely Application Submission & Follow-up
Editorial & Legal Practice Group
Authored and reviewed by the corporate law and tax litigation practice group at Javid Law Associates. Our team comprises High Court advocates, corporate legal advisors, and authorized tax practitioners across Pakistan.